Showing results (11-20 of 1,008) with videos related to
Sort By:
Pageof 101
Journal of the American Society of Nephrology : JASN|September 7, 2007
Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: data from the PROGRESS studyVlado Perkovic, Toshiharu Ninomiya, Hisatomi Arima, et al.Stroke|June 25, 2011
Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trialHisatomi Arima, Craig Anderson, Teruo Omae, et al.European Heart Journal|July 12, 2005
Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular diseaseAnushka Patel, Mark Woodward, Duncan J Campbell, et al.ANZ Journal of Surgery|November 20, 2002
Incidence of heterotopic bone formation after major hip surgeryBruce Neal, Harley Gray, Stephen MacMahon, et al.Lancet (London, England)|November 13, 2015
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysisXinfang Xie, Emily Atkins, Jicheng Lv, et al.The New Zealand Medical Journal|August 30, 2002
Leg ulcers in New Zealand: age at onset, recurrence and provision of care in an urban populationNatalie Walker, Anthony Rodgers, Nicholas Birchall, et al.Journal of Vascular Surgery|December 19, 2003
Leg ulceration as a long-term complication of deep vein thrombosisNatalie Walker, Anthony Rodgers, Nicholas Birchall, et al.The New Zealand Medical Journal|May 30, 2002
The occurrence of leg ulcers in Auckland: results of a population-based studyNatalie Walker, Anthony Rodgers, Nicholas Birchall, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 5, 2008
Blood pressure lowering with fixed combination perindopril-indapamide: key findings from ADVANCEJohn Chalmers, Rohina Joshi, Andre-Pascal Kengne, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 14, 2003
Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart diseaseBruce Neal, Stephen MacMahon, Takayoshi Ohkubo, et al.Pageof 101